 |
Physicians and scientists at Dana-Farber/Partners Cancer Care continue to explore new treatment options for cancer patients. This past year, a novel approach to cancer treatment called Photodynamic Therapy (PDT) has been introduced at Brigham and Women's Hospital. This new treatment results in the destruction of cancerous cells through the administration of light-sensitive drugs and a visible light beam.
The treatment involves the administration of a non-toxic photosensitizer drug (Photofrin) which is activated by light and appears to be retained in cancer cells longer than in normal tissues. When exposed to the specific light, the tumor cells are selectively killed. Patients who have esophageal cancer and lung cancer are potential candidates for this treatment. PDT treatments are usually performed via minimally invasive approaches and are excellent palliation options for patients with advanced cancer.
Comments about this website may be directed to: kzahner@partners.org
NOTICE: This email is not for medically related issues. Comments or concerns regarding patient-related care should be directed to the Thoracic Surgery Clinic at 617-732-6824.
©2010, Division of Thoracic Surgery at Brigham and Women's Hospital. All rights reserved.
Division of Thoracic Surgery
Brigham and Women's Hospital
75 Francis Street
Boston, MA 02115